|
Celldex breast cancer drug shrinks some tumors: study
(Reuters) - Interim results from a mid-stage trial of Celldex Therapeutics Inc's experimental drug showed trends toward reducing tumors in patients with advanced breast cancer, with rates improving for those patients with high levels of a key protein. Celldex shares dropped 8 percent in after-hours trading. The drug, CDX-011, which links a tumor-targeting antibody to a cell-killing chemotherapy ...
news.yahoo.com
Pancreatic Cancer Vaccine Shows Promise in Human Trials
A vaccine to treat deadly pancreatic cancer could be available within a couple years.
www.usnews.com
New anti-cancer drug developed
Scientists have created a new type of anti-cancer drug named BP-1-102. The drug, which can be orally administered, targets a key protein that triggers the development of many types of cancer including lung, breast and skin cancers. The development of BP-1-102 was guided by the research teams computer based molecular analysis of the cancer causing Stat 3 protein.
www.sciencedaily.com
Bayer Submits New Drug Application for Regorafenib for the Treatment of Metastatic Colorectal Cancer
WAYNE, N.J., May 23, 2012 /PRNewswire/ -- Bayer HealthCare announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the oral ...
finance.yahoo.com
Anti-cancer drug developed in Hawaii
A team of researchers say they have made a major breakthrough at the University of Hawaii Cancer Center. The scientists have designed a drug that stops the development of many different types of cancers. The research started with a computer program that modeled how thousands of different drug compounds would interact with a particular protein called Stat 3. Stat 3 is normally found in cells but ...
www.kitv.com
Cancer fighters sought for Cancer Prevention Study
What if you could prevent even one family member from hearing the words, “You have cancer”?
berksmontnews.com
Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At 2012 ASCO Annual Meeting
New data will be presented on targeted cancer treatments from the Pfizer Oncology portfolio across three key therapeutic categories, including tumors of the kidney, lung and hematologic malignancies, at the Annual Meeting of the American Society of Clinical Oncology in Chicago, IL, from June 1-5.
finance.yahoo.com
VCU Massey Cancer Center sees potential in novel leukemia treatment
Scientists at Virginia Commonwealth University Massey Cancer Center may be one step closer to developing a new therapy for acute myeloid leukemia (AML) after discovering that the targeted agents obatoclax and sorafenib kill leukemia cells much more effectively when combined than when the drugs are administered individually.
www.eurekalert.org
University of Hawaii Cancer Center researchers create new anti-cancer drug
( University of Hawaii Cancer Center ) A team of University of Hawaii Cancer Center scientists led by James Turkson, Ph.D. have created a new type of anti-cancer drug named BP-1-102. The drug, which can be orally administered, targets a key protein that triggers the development of many types of cancer including lung, breast and skin cancers. The development of BP-1-102 was guided by the research ...
www.eurekalert.org
Research and Markets: Metastatic Lung Cancer - Pipeline Review, H1 2012
Research and Markets has announced the addition of Global Markets Direct's new report "Metastatic Lung Cancer
finance.yahoo.com
|
